Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'

FRANKLIN LAKES, N.J., May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology1 and Cancer Medicine2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (AMR) infections compared to all other non-cancer patients.Key Takeaways: The Lancet Oncology (May 2025): Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospecti ...